The Cancer Research Institute named Alicia Zhou as Chief Executive Officer

Cancer Research Institute (CRI) shared on LinkedIn:

“The Cancer Research Institute is excited to announce a transformative moment in our history, with the naming of Alicia Zhou, as our Chief Executive Officer, effective August 26, 2024!

Dr. Zhou’s appointment heralds a bold new era for CRI, seamlessly integrating our key position in the immunotherapy revolution with a visionary approach to the future. Under her leadership, CRI will not only uphold our legacy of pioneering lifesaving innovations but also spearhead breakthroughs in personalized medicine, advanced vaccines, cell therapies, and gene therapies — all grounded in data- driven science and innovation. Dr. Zhou will leverage CRI’s esteemed global network of leading researchers, clinicians, and data scientists to push the boundaries of innovation.

‘I’ve seen firsthand the pivotal role strong leadership plays in driving progress,’ expresses Nobel laureate and CRI Scientific Advisory Council Director, Dr. James P. Allison. ‘I’m confident that under her direction, CRI will make great strides as we collectively work to expand the benefits of immunotherapy to more patients.’

Join us in welcoming Dr. Zhou, and look ahead into this new chapter of leadership.”

Source: Cancer Research Institute (CRI)/LinkedIn